Safe Pro Awarded U.S. Air Force SBIR Contract for AI Dataset Development for Use in Airfield Operations

Safe Pro Group Inc. (Nasdaq: SPAI) (“Safe Pro” or the “Company”), a developer of artificial intelligence (AI)-enabled defense, security, and situational awareness solutions, today announced that it ...

From Clipping Coupons to Clicking on Deals: How New York is Regulating Pricing Practices in the Digital Age

New York is regulating targeted pricing algorithms to ensure transparency and prevent discrimination. The 2025 APDA requires ...
seattlepi.com

AI in health care could save lives and money − but change won’t happen overnight

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Turgay Ayer, Georgia Institute of Technology (THE CONVERSATION) Imagine walking into ...
Reuters

FDA approves expanded use of Sanofi's type 1 diabetes drug

June 12 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved the expanded use of Sanofi's (SASY.PA), opens new tab type 1 diabetes injection in children aged 8 to ‌17 years ...
Los Angeles Business Journal

FDA to Review Expanded Use of Cancer Drug

ImmunityBio receives good news all around – the U.S. Food and Drug Administration has accepted for review the company’s application for expanded use of Anktiva and it acquired a strain of a related ...
Bleeping Computer

Chinese hackers use new Atlas RAT malware in European cyberattacks

A Chinese-speaking cybercrime group has expanded its targeting to the European space, deploying previously undocumented malware and the Atlas backdoor. Tracked as TA4922, the threat actor is ...
Bloomberg L.P.

China Adds Data and AI to Trade Secret Rules to Block Leaks

China expanded its trade secret rules to include data and algorithms, as Beijing steps up efforts to prevent technology leaks amid intensifying strategic competition with the US. Effective Monday, the ...
Seeking Alpha

J&J seeks expanded use for drug after positive head and neck cancer study

Johnson & Johnson (JNJ) reported new clinical trial results showing that its experimental subcutaneous formulation of amivantamab produced durable responses in patients with advanced head and neck ...
Fox News

New option available for Alzheimer’s patients as FDA approves expanded drug use

The U.S. Food and Drug Administration has green-lit the first-ever non-antipsychotic drug treatment for agitation in Alzheimer’s disease patients. The drug, Auvelity, was originally FDA-approved in ...
Science Daily

How personalized algorithms trick your brain into wrong answers

Personalized algorithms may quietly sabotage how people learn, nudging them into narrow tunnels of information even when they start with zero prior knowledge. In the study, participants using ...
financefeeds

Trading Technologies Expands FX Offering To Combine OTC And Listed Markets

Trading Technologies has expanded its FX functionality, extending its platform from spot trading into forwards, non-deliverable forwards and swaps while integrating additional liquidity sources. The ...